Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
RSLS ReShape Lifesciences
- 4.3800
- -0.0900-2.01%
Close Dec 20 16:00 ET
- 4.3800
- 0.00000.00%
Post 20:01 ET
3.12MMarket Cap-0.44P/E (TTM)
4.6900High4.2754Low41.47KVolume4.3800Open4.4700Pre Close185.60KTurnover6.15%Turnover RatioLossP/E (Static)712.68KShares29.000052wk High2.10P/B2.96MFloat Cap4.090052wk Low--Dividend TTM674.87KShs Float4647888000.0000Historical High--Div YieldTTM9.28%Amplitude4.0900Historical Low4.4750Avg Price1Lot Size
About ReShape Lifesciences Company
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in Irvine, CA.
Company Profile
SymbolRSLS
Company NameReShape Lifesciences
Listing DateOct 6, 2016
Issue Price15.00
Founded2002
CEOMr. Paul F. Hickey
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address18 Technology Drive,Suite 110
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-429-6680
Company Executives
- Name
- Position
- Salary
- Paul F. Hickey
- Director, President and Chief Executive Officer
- 158.08K
- Thomas Stankovich
- Chief Financial Officer, Senior Vice President and Principal Accounting Officer
- 555.84K
- Dan W. Gladney
- Executive Chairman of the Board
- 95.26K
- Dr. Arda M. Minocherhomjee, M.B.A.,PhD
- Independent Director
- 52.50K
- Gary D. Blackford
- Lead Independent Director
- 77.00K
- Lori C. McDougal
- Independent Director
- 57.50K